Bayer AG (BAYRY)
5.41
+0.05
(+0.93%)
USD |
OTCM |
Nov 14, 15:59
Bayer Market Cap: 21.26B for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 21.06B |
| November 12, 2024 | 21.93B |
| November 11, 2024 | 25.35B |
| November 08, 2024 | 25.43B |
| November 07, 2024 | 25.90B |
| November 06, 2024 | 25.31B |
| November 05, 2024 | 26.56B |
| November 04, 2024 | 26.56B |
| November 01, 2024 | 26.72B |
| October 31, 2024 | 26.60B |
| October 30, 2024 | 26.76B |
| October 29, 2024 | 27.31B |
| October 28, 2024 | 27.86B |
| October 25, 2024 | 27.47B |
| October 24, 2024 | 27.43B |
| October 23, 2024 | 27.27B |
| October 22, 2024 | 27.59B |
| October 21, 2024 | 27.78B |
| October 18, 2024 | 28.25B |
| October 17, 2024 | 28.23B |
| October 16, 2024 | 28.35B |
| October 15, 2024 | 28.41B |
| October 14, 2024 | 28.02B |
| October 11, 2024 | 28.49B |
| October 10, 2024 | 28.90B |
| Date | Value |
|---|---|
| October 09, 2024 | 29.45B |
| October 08, 2024 | 31.63B |
| October 07, 2024 | 32.14B |
| October 04, 2024 | 32.30B |
| October 03, 2024 | 32.42B |
| October 02, 2024 | 32.97B |
| October 01, 2024 | 33.05B |
| September 30, 2024 | 33.28B |
| September 27, 2024 | 33.32B |
| September 26, 2024 | 31.99B |
| September 25, 2024 | 31.56B |
| September 24, 2024 | 31.91B |
| September 23, 2024 | 31.28B |
| September 20, 2024 | 31.40B |
| September 19, 2024 | 31.75B |
| September 18, 2024 | 30.61B |
| September 17, 2024 | 29.94B |
| September 16, 2024 | 29.35B |
| September 13, 2024 | 29.51B |
| September 12, 2024 | 29.32B |
| September 11, 2024 | 29.47B |
| September 10, 2024 | 29.94B |
| September 09, 2024 | 31.23B |
| September 06, 2024 | 31.48B |
| September 05, 2024 | 31.63B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
21.06B
Minimum
Nov 13 2024
84.84B
Maximum
Jan 23 2020
54.02B
Average
56.41B
Median
Nov 15 2021
Market Cap Benchmarks
| CureVac NV | 602.28M |
| Affimed NV | 57.23M |
| InflaRx NV | 119.83M |
| BioNTech SE | 24.79B |
| Immatics NV | 876.40M |
Market Cap Related Metrics
| PS Ratio | 0.4170 |
| Price to Book Value | 0.5557 |
| Price to Free Cash Flow | 3.431 |
| Price | 5.41 |
| Earnings Yield | -6.54% |
| Operating PE Ratio | 2.051 |